Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Want to maximize your rewards? Discover what credit card has the highest rewards and make your spending work for you.
25,748 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
As Warren Buffett steps back, Berkshire Hathaway's portfolio is evolving. This guide breaks down how the post-Buffett...
Two Senate bills would let six-story apartment buildings use a single interior exit stair, a move that could lower co...
A top market analyst says the popular rotation narrative is flawed. New ETF flow data show bitcoin didn’t lose gold, ...
DeXe shows resilience as on-chain activity climbs and wallet growth accelerates amid a broader market downturn. Analy...
New York City's Rent Guidelines Board approved a rent freeze for one-year renewals and, for the first time, two-year ...
Cape Verde's Vozinha has surged to a $17 million valuation as World Cup spotlight boosts a small nation’s brand. Inve...
A new ETF strategy shifts focus from AI chipmakers to the data-center buildout, charging 0.47% and backing the compan...
Hedge funds buying amazon can hint at value in a complex market. This guide breaks down what the trend may mean for y...
Crypto venture funds are widening bets beyond coins, aiming at fintech, AI, and infrastructure. The shift is designed...
As AI accelerates, tech’s demand uninterrupted power is forcing investors to rethink NextEra Energy’s renewables-led ...
A swift rotation out of momentum bets hammered quant trading desks, delivering the year’s sharpest rout for the secto...